← Back to Search

Other

Vibration Therapy for Cerebral Palsy

N/A
Waitlist Available
Led By Christopher M Modlesky, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 6 months, 7 months, and 12 months

Summary

This trial will study the effects of low-magnitude vibration on muscle, physical activity, and balance in children with spastic cerebral palsy.

Who is the study for?
This trial is for children with spastic cerebral palsy who can walk on their own without help. They shouldn't have had certain treatments like Botox in the past year, be taking specific bone medications, or have a Baclofen pump. Also, they must not have had recent leg surgery or fractures in both femurs or tibias.
What is being tested?
The study tests if standing on a vibration platform for six months can improve muscle condition, physical activity, and balance compared to a placebo platform. After the initial period, there's another six months where no treatment is given to see lasting effects.
What are the potential side effects?
Potential side effects are not detailed but may include discomfort from standing on the vibrating platform. Since it's non-invasive and doesn't involve drugs or surgery, serious side effects are unlikely.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 6 months, 7 months, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 6 months, 7 months, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in fat concentration
Secondary study objectives
Change in dynamic balance
Change in muscle size
Change in physical activity
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Vibration PlatformExperimental Treatment1 Intervention
The vibration group will stand on a platform that emits a mild vibration 10 minutes per day for 6 months. There will also be a 6 month no-treatment period.
Group II: Placebo PlatformPlacebo Group1 Intervention
The placebo group will stand on a placebo platform 10 minutes per day for 6 months. There will also be a 6 month no-treatment period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vibration Platform
2009
Completed Phase 3
~150

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER
1,697 Previous Clinical Trials
2,603,874 Total Patients Enrolled
2 Trials studying Cerebral Palsy
309 Patients Enrolled for Cerebral Palsy
University of GeorgiaLead Sponsor
103 Previous Clinical Trials
45,014 Total Patients Enrolled
Christopher M Modlesky, PhDPrincipal InvestigatorUniversity of Georgia

Media Library

Vibration Platform (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03484078 — N/A
Cerebral Palsy Research Study Groups: Placebo Platform, Vibration Platform
Cerebral Palsy Clinical Trial 2023: Vibration Platform Highlights & Side Effects. Trial Name: NCT03484078 — N/A
Vibration Platform (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03484078 — N/A
~7 spots leftby Nov 2025